Serina Therapeutics
SER
25 hedge funds and large institutions have $2.01M invested in Serina Therapeutics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 0 closing their positions.
19% more funds holding
Funds holding: 21 → 25 (+4)
2% more capital invested
Capital invested by funds: $1.96M → $2.01M (+$44.7K)
0.94% more ownership
Funds ownership: 2.44% → 3.38% (+0.94%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Waverly Advisors
Birmingham,
Alabama
|
+$349K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$178K |
| 3 |
KP
Keel Point
Huntsville,
Alabama
|
+$141K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$117K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$19.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.14K |
| 4 |
BlackRock
New York
|
-$3.22K |
| 5 |
SIS
Strategic Investment Solutions
Orland Park,
Illinois
|
-$1.95K |
SER Hedge Fund Activity: Q3 2024 in Review
25 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q3 2024, worth a combined $2.01M — up 2.3% from $1.96M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SER positions and 0 closed out — a net gain of 4 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Waverly Advisors, adding an estimated $349K. The largest seller was Millennium Management, cutting an estimated $19.2K.
- 25 institutional investors held Serina Therapeutics (SER) as of Q3 2024, up from 21 in Q2 2024.
- Funds reported $2.01M of Serina Therapeutics stock for Q3 2024, up 2.3% quarter-over-quarter.
- 4 funds opened new Serina Therapeutics positions in Q3 2024 and 0 closed out, a net change of +4 holders.
- The largest Serina Therapeutics buyer in Q3 2024 was Waverly Advisors, an estimated $349K added.
- The largest Serina Therapeutics seller in Q3 2024 was Millennium Management, an estimated $19.2K sold.
Based on aggregated 13F filings for Q3 2024.